LIEN vs TMO · P/E 6.5, $223.4M cap vs P/E 24, rev $44.56B
Chicago Atlantic BDC, Inc. (LIEN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Chicago Atlantic BDC, Inc. (LIEN) is a asset management company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
LIEN does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
LIEN currently screens at market cap $223.4M and trailing P/E 6.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the LIEN and TMO stock pages for the full models.
Not investment advice.